Mitochondrial DNA Variant M.15218A > G in Finnish Epilepsy Patients Who Have Maternal Relatives with Epilepsy, Sensorineural Hearing Impairment or Diabetes Mellitus

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2013 Jul 23

PMID 23870133

Citations 3

Authors

Heidi K Soini

Jukka S Moilanen

Tiina Vilmi-Kerala

Saara Finnila

Kari Majamaa

Affiliations

Soon will be listed here.

Abstract

Background: Mitochondrial diseases caused by mutations in mitochondrial DNA (mtDNA) affect tissues with high energy demand. Epilepsy is one of the manifestations of mitochondrial dysfunction when the brain is affected. We have studied here 79 Finnish patients with epilepsy and who have maternal first- or second-degree relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus.

Methods: The entire mtDNA was studied by using conformation sensitive gel electrophoresis and PCR fragments that differed in mobility were directly sequenced.

Results: We found a common nonsynonymous variant m.15218A > G (p.T158A, MTCYB) that occurs in haplogroup U5a1 to be more frequent in patients with epilepsy. The m.15218A > G variant was present in five patients with epilepsy and in four out of 403 population controls (p = 0.0077). This variant was present in two branches in the phylogenetic network constructed on the basis of mtDNA variation among the patients. Three algorithms predicted that m.15218A > G is damaging in effect.

Conclusions: We suggest that the m.15218A > G variant is mildly deleterious and that mtDNA involvement should be considered in patients with epilepsy and who have a maternal history of epilepsy, sensorineural hearing impairment or diabetes mellitus.

Citing Articles

Mitochondrial DNA variants and their impact on epigenetic and biological aging in young adulthood.

Mareckova K, Mendes-Silva A, Jani M, Pacinkova A, Piler P, Goncalves V Transl Psychiatry. 2025; 15(1):16.

PMID: 39837837 PMC: 11751369. DOI: 10.1038/s41398-025-03235-4.

Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease.

Li M, Gong S, Han X, Zhou L, Zhang S, Ren Q Front Endocrinol (Lausanne). 2022; 13:953631.

PMID: 36313763 PMC: 9597463. DOI: 10.3389/fendo.2022.953631.

Identification and analysis of mtDNA genomes attributed to Finns reveal long-stagnant demographic trends obscured in the total diversity.

Oversti S, Onkamo P, Stoljarova M, Budowle B, Sajantila A, Palo J Sci Rep. 2017; 7(1):6193.

PMID: 28733587 PMC: 5522469. DOI: 10.1038/s41598-017-05673-7.

Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.

Blein S, Barjhoux L, Damiola F, Dondon M, Eon-Marchais S, Marcou M PLoS One. 2015; 10(9):e0136192.

PMID: 26406445 PMC: 4583250. DOI: 10.1371/journal.pone.0136192.

References

Legros F, Chatzoglou E, Frachon P, Ogier de Baulny H, Laforet P, Jardel C . Functional characterization of novel mutations in the human cytochrome b gene. Eur J Hum Genet. 2001; 9(7):510-8. DOI: 10.1038/sj.ejhg.5200678. View

Finnila S, Lehtonen M, Majamaa K . Phylogenetic network for European mtDNA. Am J Hum Genet. 2001; 68(6):1475-84. PMC: 1226134. DOI: 10.1086/320591. View

Wang J, Schmitt E, Landsverk M, Zhang V, Li F, Graham B . An integrated approach for classifying mitochondrial DNA variants: one clinical diagnostic laboratory's experience. Genet Med. 2012; 14(6):620-6. DOI: 10.1038/gim.2012.4. View

Chinnery P, Elliott H, Hudson G, Samuels D, Relton C . Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol. 2012; 41(1):177-87. PMC: 3304530. DOI: 10.1093/ije/dyr232. View

Ingman M, Gyllensten U . mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res. 2005; 34(Database issue):D749-51. PMC: 1347373. DOI: 10.1093/nar/gkj010. View

Waldbaum S, Patel M . Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 2009; 88(1):23-45. PMC: 3236664. DOI: 10.1016/j.eplepsyres.2009.09.020. View

Kokotas H, Grigoriadou M, Yang L, Lodahl M, Rendtorff N, Gyftodimou Y . Homoplasmy of the G7444A mtDNA and heterozygosity of the GJB2 c.35delG mutations in a family with hearing loss. Int J Pediatr Otorhinolaryngol. 2010; 75(1):89-94. DOI: 10.1016/j.ijporl.2010.10.016. View

Yuan H, Qian Y, Xu Y, Cao J, Bai L, Shen W . Cosegregation of the G7444A mutation in the mitochondrial COI/tRNA(Ser(UCN)) genes with the 12S rRNA A1555G mutation in a Chinese family with aminoglycoside-induced and nonsyndromic hearing loss. Am J Med Genet A. 2005; 138A(2):133-40. PMC: 2759106. DOI: 10.1002/ajmg.a.30952. View

Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, Wareham N . Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case-control study. Hum Mol Genet. 2002; 11(13):1581-3. DOI: 10.1093/hmg/11.13.1581. View

10.

Korkko J, Annunen S, Pihlajamaa T, Prockop D, Ala-Kokko L . Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci U S A. 1998; 95(4):1681-5. PMC: 19147. DOI: 10.1073/pnas.95.4.1681. View

11.

Varlamov D, Kudin A, Vielhaber S, Schroder R, Sassen R, Becker A . Metabolic consequences of a novel missense mutation of the mtDNA CO I gene. Hum Mol Genet. 2002; 11(16):1797-805. DOI: 10.1093/hmg/11.16.1797. View

12.

Seoane M, Mosquera-Miguel A, Gonzalez T, Fraga M, Salas A, Costoya J . The mitochondrial genome is a "genetic sanctuary" during the oncogenic process. PLoS One. 2011; 6(8):e23327. PMC: 3157371. DOI: 10.1371/journal.pone.0023327. View

13.

Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus G, Radi E . Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci. 2012; 322(1-2):254-62. DOI: 10.1016/j.jns.2012.05.030. View

14.

Rubino F, Piredda R, Calabrese F, Simone D, Lang M, Calabrese C . HmtDB, a genomic resource for mitochondrion-based human variability studies. Nucleic Acids Res. 2011; 40(Database issue):D1150-9. PMC: 3245114. DOI: 10.1093/nar/gkr1086. View

15.

Shoffner J, Lott M, Lezza A, Seibel P, Ballinger S, Wallace D . Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell. 1990; 61(6):931-7. DOI: 10.1016/0092-8674(90)90059-n. View

16.

Meinila M, Finnila S, Majamaa K . Evidence for mtDNA admixture between the Finns and the Saami. Hum Hered. 2001; 52(3):160-70. DOI: 10.1159/000053372. View

17.

Gasparre G, Porcelli A, Bonora E, Pennisi L, Toller M, Iommarini L . Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A. 2007; 104(21):9001-6. PMC: 1885617. DOI: 10.1073/pnas.0703056104. View

18.

Coskun P, Wyrembak J, Schriner S, Chen H, Marciniack C, LaFerla F . A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta. 2011; 1820(5):553-64. PMC: 3270155. DOI: 10.1016/j.bbagen.2011.08.008. View

19.

Cai W, Fu Q, Zhou X, Qu J, Tong Y, Guan M . Mitochondrial variants may influence the phenotypic manifestation of Leber's hereditary optic neuropathy-associated ND4 G11778A mutation. J Genet Genomics. 2008; 35(11):649-55. DOI: 10.1016/S1673-8527(08)60086-7. View

20.

Sproule D, Kaufmann P . Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci. 2008; 1142:133-58. DOI: 10.1196/annals.1444.011. View